Cargando…

Propofol suppresses the progression of non-small cell lung cancer via downregulation of the miR-21-5p/MAPK10 axis

Non-small cell lung cancer (NSCLC) accounts for >80% of lung cancer cases and is the leading cause of cancer-associated mortality worldwide. Propofol is an anesthetic drug frequently used during tumor resection. It is also known to exert inhibitory effects on cancer. Although the role of propofol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinhua, Li, Xuebin, Xu, Guiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336515/
https://www.ncbi.nlm.nih.gov/pubmed/32468043
http://dx.doi.org/10.3892/or.2020.7619

Ejemplares similares